In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glyceroltrinitrat Drug Master File in Korea (Glyceroltrinitrat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glyceroltrinitrat. The MFDS reviews the Glyceroltrinitrat KDMF as part of the drug registration process and uses the information provided in the Glyceroltrinitrat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glyceroltrinitrat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glyceroltrinitrat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glyceroltrinitrat suppliers with KDMF on PharmaCompass.